Organon (NYSE: OGN) reported Q2 EPS of $1.72, $0.30 better than the analyst estimate of $1.42. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.52 billion.

GUIDANCE:

Organon sees FY2021 revenue of $6.1-6.4 billion, versus the consensus of $6.25 billion.

For earnings history and earnings-related data on Organon (OGN) click here.